TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Kubator Therapeutics AB
Closing information (x1000 SEK)
| Closing information | 2024/01 | 2023/01 | 2022/01 |
| Turnover |
2,623
|
2,927
|
2,390 |
| Financial expenses |
434
|
62
|
0 |
| Earnings before taxes |
1,436
|
1,730
|
818 |
| EBITDA |
1,734
|
1,691
|
773 |
| Total assets |
5,156
|
4,331
|
3,309 |
| Current assets |
3,542
|
2,588
|
1,714 |
| Current liabilities |
2,108
|
1,460
|
1,864 |
| Equity capital |
2,735
|
2,655
|
1,285 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Solvency |
53.0%
|
61.3%
|
38.8% |
| Turnover per employee |
2,623
|
2,927
|
2,390 |
| Profit as a percentage of turnover |
54.7%
|
59.1%
|
34.2% |
| Return on assets (ROA) |
36.3%
|
41.4%
|
24.7% |
| Current ratio |
168.0%
|
177.3%
|
92.0% |
| Return on equity (ROE) |
52.5%
|
65.2%
|
63.7% |
| Change turnover |
-304
|
537
|
735 |
| Change turnover % |
-10%
|
22%
|
44% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.